Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fagioli

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
Frontiers in Pediatrics|August 1, 2024
Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patientsA Neirotti, V Barat, P Coppo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyG Grignani, E Palmerini, P Dileo, et al.
Blood|August 29, 2000
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trialF Locatelli, B Bruno, M Zecca, et al.
Cancer|January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin diseaseM Aglietta, F Montemurro, F Fagioli, et al.
Blood|April 18, 1998
c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cellsE Ricotti, F Fagioli, E Garelli, et al.
Leukemia|October 26, 2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donorsF Locatelli, M Zecca, C Messina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation GroupF Bonetti, M Zecca, A Pession, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Leukemia|June 18, 2004
Clinical features of childhood acute myeloid leukaemia with specific gene rearrangementsE Frascella, R Rondelli, M Pigazzi, et al.
BMC Cancer|April 22, 2016
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneE Palmerini, R L Jones, E Marchesi, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
Frontiers in Pediatrics|August 1, 2024
Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patientsA Neirotti, V Barat, P Coppo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 30, 2011
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group studyG Grignani, E Palmerini, P Dileo, et al.
Blood|August 29, 2000
Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trialF Locatelli, B Bruno, M Zecca, et al.
Cancer|January 21, 2000
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin diseaseM Aglietta, F Montemurro, F Fagioli, et al.
Blood|April 18, 1998
c-kit is expressed in soft tissue sarcoma of neuroectodermic origin and its ligand prevents apoptosis of neoplastic cellsE Ricotti, F Fagioli, E Garelli, et al.
Leukemia|October 26, 2002
Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donorsF Locatelli, M Zecca, C Messina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation GroupF Bonetti, M Zecca, A Pession, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2011
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patientsM Berger, G Grignani, A Giostra, et al.
Leukemia|June 18, 2004
Clinical features of childhood acute myeloid leukaemia with specific gene rearrangementsE Frascella, R Rondelli, M Pigazzi, et al.
BMC Cancer|April 22, 2016
Gemcitabine and docetaxel in relapsed and unresectable high-grade osteosarcoma and spindle cell sarcoma of boneE Palmerini, R L Jones, E Marchesi, et al.
Pageof 13